SE0100902D0 - Compounds - Google Patents
CompoundsInfo
- Publication number
- SE0100902D0 SE0100902D0 SE0100902A SE0100902A SE0100902D0 SE 0100902 D0 SE0100902 D0 SE 0100902D0 SE 0100902 A SE0100902 A SE 0100902A SE 0100902 A SE0100902 A SE 0100902A SE 0100902 D0 SE0100902 D0 SE 0100902D0
- Authority
- SE
- Sweden
- Prior art keywords
- compounds
- inhibitors
- mmp12
- useful
- formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
- C07D233/78—Radicals substituted by oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/72—Two oxygen atoms, e.g. hydantoin
- C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Priority Applications (117)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100902A SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Compounds |
CNA028100417A CN1509275A (zh) | 2001-03-15 | 2002-03-13 | 金属蛋白酶抑制剂 |
DE60237965T DE60237965D1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinaseinhibitoren |
KR1020087017665A KR100879905B1 (ko) | 2001-03-15 | 2002-03-13 | 메탈로프로테이나제 억제제 |
PL364706A PL205315B1 (pl) | 2001-03-15 | 2002-03-13 | Pochodne imidazolidynodionu, środek farmaceutyczny i zastosowanie tych pochodnych |
EEP200300445A EE05431B1 (et) | 2001-03-15 | 2002-03-13 | Metalloproteinaasi inhibiitorid |
UA2003098168A UA77408C2 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors, pharmaceutical composition on its base, and use thereof |
SK1095-2003A SK10952003A3 (sk) | 2001-03-15 | 2002-03-13 | Metaloproteinázové inhibítory |
RU2003127735/04A RU2293729C2 (ru) | 2001-03-15 | 2002-03-13 | Ингибиторы металлопротеиназ, их применение и фармацевтические композиции на их основе |
EP02704032A EP1370534A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
NZ528106A NZ528106A (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
US10/471,810 US7368465B2 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
US10/471,808 US20040147573A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
UA2003098170A UA77667C2 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors, pharmaceutical composition and use thereof |
CZ20032502A CZ20032502A3 (cs) | 2001-03-15 | 2002-03-13 | Inhibitory metalloproteinasy |
EP02704031A EP1370556B1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
IL15765602A IL157656A0 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
SK1096-2003A SK287766B6 (sk) | 2001-03-15 | 2002-03-13 | Metaloproteinázové inhibítory |
BR0208105-9A BR0208105A (pt) | 2001-03-15 | 2002-03-13 | Inibidores de metaloproteinase |
ES06008158T ES2357138T3 (es) | 2001-03-15 | 2002-03-13 | Derivados de hidantoína como inhibidores de mmp. |
JP2002573759A JP2004527511A (ja) | 2001-03-15 | 2002-03-13 | メタロプロテイナーゼ阻害剤 |
HU0400202A HUP0400202A3 (en) | 2001-03-15 | 2002-03-13 | Imidazolidindion derivatives having metalloproteinase inhibitor effect, their use and pharmaceutical compositions containing them |
RU2003127733/04A RU2285695C2 (ru) | 2001-03-15 | 2002-03-13 | Производные имидазолидин-2,4-диона, содержащие их фармацевтические композиции и их применение |
DE60213216T DE60213216T2 (de) | 2001-03-15 | 2002-03-13 | Metalloproteinaseinhibitoren |
PT02704031T PT1370556E (pt) | 2001-03-15 | 2002-03-13 | Inibidores de metaloproteinases |
EP06008158A EP1676846B1 (en) | 2001-03-15 | 2002-03-13 | Hydantoin derivatives as MMP inhibitors |
EEP200300439A EE200300439A (et) | 2001-03-15 | 2002-03-13 | Metalloproteinaasi inhibiitorid |
SK1093-2003A SK10932003A3 (sk) | 2001-03-15 | 2002-03-13 | Metaloproteinázové inhibítory |
BR0207984-4A BR0207984A (pt) | 2001-03-15 | 2002-03-13 | Inibidores de metaloproteinase |
JP2002573776A JP2004527515A (ja) | 2001-03-15 | 2002-03-13 | メタロプロテイナーゼ阻害剤 |
ES02704037T ES2352246T3 (es) | 2001-03-15 | 2002-03-13 | Inhibidores de metaloproteinasas. |
SI200230386T SI1370556T1 (sl) | 2001-03-15 | 2002-03-13 | Metaloproteinazni inhibitorji |
CN2006101061525A CN1962641B (zh) | 2001-03-15 | 2002-03-13 | 金属蛋白酶抑制剂 |
KR1020037011987A KR100886315B1 (ko) | 2001-03-15 | 2002-03-13 | 메탈로프로테이나제 억제제 |
MXPA03008177A MXPA03008177A (es) | 2001-03-15 | 2002-03-13 | Inhibidores de metaloproteinasa.. |
SK1092-2003A SK287834B6 (sk) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
US10/471,900 US7427631B2 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
PL02364707A PL364707A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
HU0400194A HUP0400194A3 (en) | 2001-03-15 | 2002-03-13 | Imidazolidindion derivatives as metalloproteinase inhibitors, their use and pharmaceutical compositions containing them |
MXPA03008181A MXPA03008181A (es) | 2001-03-15 | 2002-03-13 | Inhibidores de metaloproteinasa. |
RU2003127732/04A RU2003127732A (ru) | 2001-03-15 | 2002-03-13 | Ингибиторы металлопротеиназ |
CNA200910147512XA CN101602731A (zh) | 2001-03-15 | 2002-03-13 | 金属蛋白酶抑制剂 |
CA2440630A CA2440630C (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
KR10-2003-7011989A KR20030082990A (ko) | 2001-03-15 | 2002-03-13 | 메탈로프로테이나제 억제제 |
EEP200300451A EE05364B1 (et) | 2001-03-15 | 2002-03-13 | Metalloproteinaasi inhibiitorid |
PCT/SE2002/000475 WO2002074750A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
JP2002573757A JP2004523581A (ja) | 2001-03-15 | 2002-03-13 | メタロプロテイナーゼ阻害剤 |
AU2002237632A AU2002237632B2 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
MXPA03008180A MXPA03008180A (es) | 2001-03-15 | 2002-03-13 | Inhibidores de metaloproteinasa. |
CA002440631A CA2440631A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
KR10-2003-7011981A KR20030082986A (ko) | 2001-03-15 | 2002-03-13 | 메탈로프로테이나제 억제제 |
KR10-2003-7011982A KR20030082987A (ko) | 2001-03-15 | 2002-03-13 | 메탈로프로테이나제 억제제 |
NZ528107A NZ528107A (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
CZ20032500A CZ20032500A3 (cs) | 2001-03-15 | 2002-03-13 | Inhibitory metalloproteinasy |
EP02704034A EP1370536A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
BR0208104-0A BR0208104A (pt) | 2001-03-15 | 2002-03-13 | Inibidores de metaloproteinase |
MYPI20020904A MY136141A (en) | 2001-03-15 | 2002-03-13 | Novel hydantoin derivatives and pharmaceutical compositions useful as metalloproteinase inhibitors |
AU2002237626A AU2002237626B2 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
CNB02809915XA CN100526307C (zh) | 2001-03-15 | 2002-03-13 | 金属蛋白酶抑制剂 |
ES02704031T ES2267986T3 (es) | 2001-03-15 | 2002-03-13 | Inhibidores de metaloproteinasas. |
AT02704031T ATE333454T1 (de) | 2001-03-15 | 2002-03-13 | Metalloproteinaseinhibitoren |
US10/471,500 US20040106659A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
PL02364714A PL364714A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
UA2003098171A UA78502C2 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors, use thereof, and pharmaceutical composition based thereon |
AT06008158T ATE493406T1 (de) | 2001-03-15 | 2002-03-13 | Hydantoinderivate als mmp-inhibitoren |
DK02704031T DK1370556T3 (da) | 2001-03-15 | 2002-03-13 | Metalloproteinaseinhibitorer |
NZ528140A NZ528140A (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
CZ20032497A CZ20032497A3 (cs) | 2001-03-15 | 2002-03-13 | Inhibitory metalloproteinasy |
HU0400327A HUP0400327A3 (en) | 2001-03-15 | 2002-03-13 | Azole derivatives having metalloproteinase inhibitor effect pharmaceutical compositions containing them and their use |
EEP200300449A EE200300449A (et) | 2001-03-15 | 2002-03-13 | Metalloproteinaasi inhibiitorid |
PCT/SE2002/000478 WO2002074751A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
MYPI20020910A MY136789A (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
DE60238794T DE60238794D1 (de) | 2001-03-15 | 2002-03-13 | Hydantoinderivate als MMP-Inhibitoren |
HU0400206A HUP0400206A3 (en) | 2001-03-15 | 2002-03-13 | Imidazolidindion derivatives having metalloproteinase inhibitor effect a their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing them |
PCT/SE2002/000472 WO2002074767A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
CNB02810093XA CN1269804C (zh) | 2001-03-15 | 2002-03-13 | 金属蛋白酶抑制剂 |
MXPA03008191A MXPA03008191A (es) | 2001-03-15 | 2002-03-13 | Inhibidores de metaloproteinasa. |
RU2003127734/04A RU2288228C2 (ru) | 2001-03-15 | 2002-03-13 | Ингибиторы металлопротеиназ, их применение и фармацевтические композиции на их основе |
CZ20032499A CZ20032499A3 (cs) | 2001-03-15 | 2002-03-13 | Inhibitory metaloproteinasy |
IL15765202A IL157652A0 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
PCT/SE2002/000473 WO2002074748A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
CA2440473A CA2440473C (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
JP2002573760A JP4390457B2 (ja) | 2001-03-15 | 2002-03-13 | メタロプロテイナーゼ阻害剤 |
AT02704037T ATE484496T1 (de) | 2001-03-15 | 2002-03-13 | Metalloproteinaseinhibitoren |
IL15757002A IL157570A0 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
IL15765702A IL157657A0 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
BR0207983-6A BR0207983A (pt) | 2001-03-15 | 2002-03-13 | Inibidores de metaloproteinase |
CA002440632A CA2440632A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
EP02704037A EP1370537B1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
PL02365099A PL365099A1 (en) | 2001-03-15 | 2002-03-13 | Metalloproteinase inhibitors |
CNB028097882A CN1304377C (zh) | 2001-03-15 | 2002-03-13 | 金属蛋白酶抑制剂 |
ARP020100943A AR035695A1 (es) | 2001-03-15 | 2002-03-15 | Compuestos inhibidores de metaloproteinasa, composicion farmaceutica, metodo de tratamiento, y uso de estos compuestos para la preparacion de medicamentos |
ARP020100944A AR035443A1 (es) | 2001-03-15 | 2002-03-15 | Compuestos inhibidores de metaloproteinasa, composicion farmaceutica, metodo de tratamiento, y uso de estos compuestos para la preparacion de medicamentos. |
IL157656A IL157656A (en) | 2001-03-15 | 2003-08-28 | Metalloproteinase inhibitors, pharmaceutical compositions comprising them and use thereof in the preparation of medicaments for the treatment of diseases mediated by metalloproteinase enzymes |
ZA200306732A ZA200306732B (en) | 2001-03-15 | 2003-08-28 | Metalloproteinase inhibitors. |
IL157652A IL157652A (en) | 2001-03-15 | 2003-08-28 | Metalloproteinase inhibitors, compositions comprising them and uses thereof for the preparation of medicaments for treating diseases or conditions mediated by metalloproteinase enzymes |
ZA200306734A ZA200306734B (en) | 2001-03-15 | 2003-08-28 | Metalloproteinase inhibitors. |
ZA200306737A ZA200306737B (en) | 2001-03-15 | 2003-08-28 | Metalloproteinase inhibitors. |
ZA200306731A ZA200306731B (en) | 2001-03-15 | 2003-08-28 | Metalloproteinase inhibitors. |
IS6942A IS6942A (is) | 2001-03-15 | 2003-09-09 | Málmpróteinasatálmar |
IS6943A IS6943A (is) | 2001-03-15 | 2003-09-09 | Málmpróteinasatálmar |
IS6944A IS6944A (is) | 2001-03-15 | 2003-09-10 | Málmpróteinasatálmar |
IS6946A IS6946A (is) | 2001-03-15 | 2003-09-10 | Málmpróteinasatálmar |
NO20034025A NO20034025L (no) | 2001-03-15 | 2003-09-11 | Metalloproteinaseinhibitorer |
NO20034045A NO327114B1 (no) | 2001-03-15 | 2003-09-12 | Metallproteinaseinhibitorer, farmasoytiske sammensetninger som omfatter slike, og anvendelser derav. |
NO20034044A NO20034044L (no) | 2001-03-15 | 2003-09-12 | Metallproteinase-inhibitorer |
NO20034042A NO326087B1 (no) | 2001-03-15 | 2003-09-12 | Metallproteinaseinhibitorer, farmasoytiske sammensetninger inneholdende slike samt anvendelser derav |
HK06112181.8A HK1091492A1 (en) | 2001-03-15 | 2004-04-21 | Hydantoin derivatives as mmp inhibitors |
HK04102796A HK1059932A1 (en) | 2001-03-15 | 2004-04-21 | Metalloproteinase inhibitors |
HK04102888.7A HK1060121A1 (en) | 2001-03-15 | 2004-04-23 | Metalloproteinase inhibitors |
CY20061101477T CY1107525T1 (el) | 2001-03-15 | 2006-10-13 | Αναστολεiς μεταλλοπρωτεϊνασης |
US11/928,040 US7625934B2 (en) | 2001-03-15 | 2007-10-30 | Metalloproteinase inhibitors |
US12/114,901 US7666892B2 (en) | 2001-03-15 | 2008-05-05 | Metalloproteinase inhibitors |
US12/115,785 US7754750B2 (en) | 2001-03-15 | 2008-05-06 | Metalloproteinase inhibitors |
JP2009256358A JP5140058B2 (ja) | 2001-03-15 | 2009-11-09 | メタロプロテイナーゼ阻害剤 |
US12/693,852 US8153673B2 (en) | 2001-03-15 | 2010-01-26 | Metalloproteinase inhibitors |
US12/830,763 US20110003853A1 (en) | 2001-03-15 | 2010-07-06 | Metalloproteinase Inhibitors |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0100902A SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SE0100902D0 true SE0100902D0 (sv) | 2001-03-15 |
Family
ID=20283374
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE0100902A SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Compounds |
Country Status (33)
Country | Link |
---|---|
US (8) | US7427631B2 (hu) |
EP (4) | EP1370556B1 (hu) |
JP (4) | JP4390457B2 (hu) |
KR (4) | KR100886315B1 (hu) |
CN (5) | CN100526307C (hu) |
AR (2) | AR035695A1 (hu) |
AT (3) | ATE484496T1 (hu) |
AU (2) | AU2002237632B2 (hu) |
BR (3) | BR0207984A (hu) |
CA (3) | CA2440473C (hu) |
CY (1) | CY1107525T1 (hu) |
CZ (3) | CZ20032500A3 (hu) |
DE (3) | DE60238794D1 (hu) |
DK (1) | DK1370556T3 (hu) |
EE (3) | EE05364B1 (hu) |
ES (3) | ES2267986T3 (hu) |
HK (3) | HK1091492A1 (hu) |
HU (3) | HUP0400327A3 (hu) |
IL (5) | IL157657A0 (hu) |
IS (3) | IS6942A (hu) |
MX (3) | MXPA03008177A (hu) |
MY (2) | MY136141A (hu) |
NO (3) | NO326087B1 (hu) |
NZ (3) | NZ528107A (hu) |
PL (3) | PL364707A1 (hu) |
PT (1) | PT1370556E (hu) |
RU (3) | RU2285695C2 (hu) |
SE (1) | SE0100902D0 (hu) |
SI (1) | SI1370556T1 (hu) |
SK (3) | SK287834B6 (hu) |
UA (3) | UA77667C2 (hu) |
WO (3) | WO2002074748A1 (hu) |
ZA (4) | ZA200306734B (hu) |
Families Citing this family (66)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE0100903D0 (sv) * | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
JP2004535411A (ja) | 2001-05-25 | 2004-11-25 | ブリストルーマイヤーズ スクイブ カンパニー | マトリックスメタロプロテナーゼ及び/またはTNF−α転換酵素(TACE)の阻害剤としてのヒダントイン及び関連複素環化合物 |
SE0103710D0 (sv) | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
DE10221018A1 (de) * | 2002-05-11 | 2003-11-27 | Boehringer Ingelheim Pharma | Verwendung von Hemmern der EGFR-vermittelten Signaltransduktion zur Behandlung von gutartiger Prostatahyperplasie (BPH)/Prostatahypertrophie |
SE0202539D0 (sv) * | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
SE0202693D0 (sv) * | 2002-09-11 | 2002-09-11 | Astrazeneca Ab | Compounds |
GB0221246D0 (en) * | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
AU2003282920A1 (en) * | 2002-10-04 | 2004-05-04 | Bristol-Myers Squibb Company | Hydantoin derivatives as inhibitors of matrix metalloproteinases and/or tnf-alpha converting enzyme (tace) |
JP4866610B2 (ja) | 2003-08-18 | 2012-02-01 | 富士フイルムファインケミカルズ株式会社 | ピリジルテトラヒドロピリジン類およびピリジルピペリジン類 |
WO2005090316A1 (en) * | 2004-03-12 | 2005-09-29 | Wyeth | HYDANTOINS HAVING RNase MODULATORY ACTIVITY |
SE0401763D0 (sv) * | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Compounds |
US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0401762D0 (sv) | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
JP2008512463A (ja) * | 2004-09-08 | 2008-04-24 | ボーイズ タウン ナショナル リサーチ ホスピタル | マトリックスメタロプロテイナーゼ−12に関連する糸球体基底膜疾患の治療 |
EP2316458A1 (en) | 2004-09-20 | 2011-05-04 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
EP2289510A1 (en) * | 2004-09-20 | 2011-03-02 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives for the treatment of diseases mediated by stearoyl-coa desaturase enzymes |
WO2006034440A2 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
CN101084212A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为硬脂酰CoA去饱和酶介导剂的用途 |
CN101084207A (zh) | 2004-09-20 | 2007-12-05 | 泽农医药公司 | 杂环衍生物及其作为硬脂酰CoA去饱和酶抑制剂的用途 |
US7592343B2 (en) | 2004-09-20 | 2009-09-22 | Xenon Pharmaceuticals Inc. | Pyridazine-piperazine compounds and their use as stearoyl-CoA desaturase inhibitors |
MX2007003321A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como agentes terapeuticos. |
GB0427403D0 (en) * | 2004-12-15 | 2005-01-19 | Astrazeneca Ab | Novel compounds I |
SE0403085D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
SE0403086D0 (sv) * | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
MX2007011378A (es) * | 2005-03-16 | 2008-03-18 | Sensus Metering Systems Inc | Metodo, sistema, aparato y producto de programa de computadora para determinar la ubicacion fisica de un sensor. |
CN101208089A (zh) | 2005-06-03 | 2008-06-25 | 泽农医药公司 | 氨基噻唑衍生物作为人硬酯酰-CoA去饱和酶抑制剂 |
EP1968961A2 (en) * | 2005-12-21 | 2008-09-17 | Decode Genetics EHF | Biaryl nitrogen heterocycle inhibitors of lta4h for treating inflammation |
PE20071240A1 (es) | 2006-01-17 | 2008-01-14 | Schering Corp | Compuestos derivados de hidantoina para el tratamiento de trastornos inflamatorios |
TW200800954A (en) * | 2006-03-16 | 2008-01-01 | Astrazeneca Ab | Novel crystal modifications |
TW200740769A (en) * | 2006-03-16 | 2007-11-01 | Astrazeneca Ab | Novel process |
WO2007133128A1 (en) * | 2006-05-12 | 2007-11-22 | Sca Hygiene Products Ab | Elastic laminate and a method for producing an elastic laminate |
MX2008014154A (es) * | 2006-05-12 | 2008-11-18 | Sca Hygiene Prod Ab | Articulo absorbente del tipo de calzoncillos y un metodo para producir articulos absorbentes de tipo de calzoncillos. |
WO2008053199A1 (en) * | 2006-10-30 | 2008-05-08 | Astrazeneca Ab | Combination therapy for the treatment of respiratory diseases |
TW200831488A (en) | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
GB0702456D0 (en) | 2007-02-08 | 2007-03-21 | Astrazeneca Ab | New combination |
WO2009007747A2 (en) * | 2007-07-11 | 2009-01-15 | Astrazeneca Ab | Hydantoin derivatives used as mmp12 inhibitors |
US20100262110A1 (en) | 2007-11-14 | 2010-10-14 | Sca Hygiene Products Ab | Method of producing an absorbent garment, and an absorbent garment produced according to the method |
BRPI0722260A2 (pt) | 2007-11-14 | 2014-04-01 | Sca Hygiene Prod Ab | Método de produção de um vestuário absorvente, e um vestuário absorvente produzido de acordo com o método |
FR2927330B1 (fr) * | 2008-02-07 | 2010-02-19 | Sanofi Aventis | Derives de 5,6-bisaryl-2-pyridine-carboxamide, leur preparation et leur application en therapeutique comme antagonistes des recepteurs a l'urotensine ii |
JP5539965B2 (ja) | 2008-04-28 | 2014-07-02 | レバレジオ コーポレイション | 多発性硬化症を治療するための組成物および方法 |
FR2944524B1 (fr) * | 2009-04-17 | 2012-11-30 | Ipsen Pharma Sas | Derives d'imidazolidine-2,4-dione et leur utilisation comme medicament |
WO2010126030A1 (ja) * | 2009-04-28 | 2010-11-04 | 中外製薬株式会社 | スピロイミダゾロン誘導体 |
GB0913345D0 (en) | 2009-07-31 | 2009-09-16 | Astrazeneca Ab | New combination 802 |
WO2011054734A1 (de) * | 2009-11-06 | 2011-05-12 | Basf Se | Eisen- und manganhaltiger heterogenkatalysator und verfahren zur herstellung von olefinen durch umsetzung von kohlenmonoxid mit wasserstoff |
WO2011061527A1 (en) | 2009-11-17 | 2011-05-26 | Astrazeneca Ab | Combinations comprising a glucocorticoid receptor modulator for the treatment of respiratory diseases |
WO2011073662A1 (en) | 2009-12-17 | 2011-06-23 | Astrazeneca Ab | Combination of a benzoxazinone and a further agent for treating respiratory diseases |
US20110202284A1 (en) * | 2010-02-10 | 2011-08-18 | Mcreynolds Cristopher | Novel groups of biomarkers for diagnosing alzheimer's disease |
AU2011261375B2 (en) | 2010-06-04 | 2016-09-22 | Albany Molecular Research, Inc. | Glycine transporter-1 inhibitors, methods of making them, and uses thereof |
GB201021979D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | New compound |
GB201021992D0 (en) | 2010-12-23 | 2011-02-02 | Astrazeneca Ab | Compound |
BR112015004637B1 (pt) * | 2012-09-04 | 2022-04-05 | Shanghai Hengrui Pharmaceutical Co., Ltd. | Derivados de imidazolina, seus usos e seus processos de preparação, e composição farmacêutica |
JP5951799B2 (ja) | 2012-12-10 | 2016-07-13 | 中外製薬株式会社 | ヒダントイン誘導体 |
WO2015071534A1 (en) * | 2013-11-13 | 2015-05-21 | Hankkija Oy | A feed supplement and a feed composition comprising resin acid based composition |
EP3089975B1 (en) * | 2013-12-31 | 2018-06-06 | Ipsen Pharma S.A.S. | Novel imidazolidine-2, 4-dione derivatives |
EP2907512A1 (en) | 2014-02-14 | 2015-08-19 | Commissariat A L'energie Atomique Et Aux Energies Alternatives | Inhibitors of MMP-12 as antiviral Agents |
CN106572994B (zh) * | 2014-06-09 | 2020-09-18 | 中外制药株式会社 | 含有乙内酰脲衍生物的药物组合物 |
PL3209655T3 (pl) | 2014-10-24 | 2020-12-28 | Landos Biopharma, Inc. | Leczenie oparte na białku 2 podobnym do syntetazy lantioniny C |
JO3501B1 (ar) | 2014-12-22 | 2020-07-05 | Servier Lab | مشتقات 5-{(بيبرازين - 1-يل)-3-أوكسو - بروبيل}- إيميدازوليدين-2، 4 - دايون كمثبطات ل adamts لمعالجة هشاشة العظام) |
CN109803961B (zh) * | 2016-09-23 | 2021-03-23 | 科研制药株式会社 | (r)-5-(3,4-二氟苯基)-5-[(3-甲基-2-氧代吡啶-1(2h)-基)甲基]咪唑烷-2,4-二酮的制造方法及用于该制造的中间体 |
WO2021011723A1 (en) * | 2019-07-18 | 2021-01-21 | Avidence Therapeutics, Inc. | Anti-osteoarthritis hydantoin compounds and related compositions and methods |
CN115667227A (zh) * | 2019-11-14 | 2023-01-31 | 逸达生物科技股份有限公司 | 基质金属蛋白酶(mmp)抑制剂及其使用方法 |
JP7430852B2 (ja) | 2019-12-20 | 2024-02-14 | エヌイミューン バイオファーマ インコーポレイテッド | ランチオニンc様タンパク質2リガンド、それを用いて調製される細胞、およびそれを使用する療法 |
JP2023533462A (ja) | 2020-06-26 | 2023-08-03 | ザ ユニバーシティ オブ バーミンガム | 脊髄損傷または関連する神経組織の損傷を治療するためのmmp-9及びmmp-12の阻害 |
WO2022007866A1 (zh) * | 2020-07-09 | 2022-01-13 | 深圳信立泰药业股份有限公司 | 并三环类衍生物、其制备方法及其在医药上的应用 |
CN112574193B (zh) * | 2020-12-31 | 2022-05-17 | 南京医科大学 | 一类口服gsnor抑制剂及其药物用途 |
Family Cites Families (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2327890A (en) * | 1940-04-17 | 1943-08-24 | Parke Davis & Co | Substituted phenoxyalkyl ethers |
US2745875A (en) | 1953-06-30 | 1956-05-15 | Hoechst Ag | Preparation of nu-acylamino-phenylpropane diols |
US3452040A (en) * | 1966-01-05 | 1969-06-24 | American Home Prod | 5,5-disubstituted hydantoins |
US3529019A (en) * | 1968-04-23 | 1970-09-15 | Colgate Palmolive Co | Alkylaryloxy alanines |
CS152617B1 (hu) | 1970-12-29 | 1974-02-22 | ||
CS151744B1 (hu) | 1971-01-19 | 1973-11-19 | ||
US3849574A (en) * | 1971-05-24 | 1974-11-19 | Colgate Palmolive Co | Alpha-substituted-beta-arylthioalkyl amino-acids,for increasing heart rate |
US4315031A (en) | 1977-09-01 | 1982-02-09 | Science Union Et Cie | Thiosubstituted amino acids |
GB1601310A (en) * | 1978-05-23 | 1981-10-28 | Lilly Industries Ltd | Aryl hydantoins |
JPS6172762A (ja) | 1984-09-17 | 1986-04-14 | Kanegafuchi Chem Ind Co Ltd | 光学活性ヒダントイン類の製造法 |
JPS61212292A (ja) * | 1985-03-19 | 1986-09-20 | Mitsui Toatsu Chem Inc | D−α−アミノ酸の製造方法 |
CA1325222C (en) | 1985-08-23 | 1993-12-14 | Lederle (Japan), Ltd. | Process for producing 4-biphenylylacetic acid |
GB8618559D0 (en) | 1986-07-30 | 1986-09-10 | Genetics Int Inc | Rhodococcus bacterium |
JPH0279879A (ja) | 1988-09-17 | 1990-03-20 | Canon Inc | 画像形成装置 |
US4983771A (en) | 1989-09-18 | 1991-01-08 | Hexcel Corporation | Method for resolution of D,L-alpha-phenethylamine with D(-)mandelic acid |
NL9000386A (nl) | 1990-02-16 | 1991-09-16 | Stamicarbon | Werkwijze voor de bereiding van optisch aktief aminozuuramide. |
DK161690D0 (da) | 1990-07-05 | 1990-07-05 | Novo Nordisk As | Fremgangsmaade til fremstilling af enantiomere forbindelser |
IL99957A0 (en) | 1990-11-13 | 1992-08-18 | Merck & Co Inc | Piperidinylcamphorsulfonyl oxytocin antagonists and pharmaceutical compositions containing them |
PH31245A (en) * | 1991-10-30 | 1998-06-18 | Janssen Pharmaceutica Nv | 1,3-Dihydro-2H-imidazoÄ4,5-BÜ-quinolin-2-one derivatives. |
US5308853A (en) * | 1991-12-20 | 1994-05-03 | Warner-Lambert Company | Substituted-5-methylidene hydantoins with AT1 receptor antagonist properties |
US5246943A (en) | 1992-05-19 | 1993-09-21 | Warner-Lambert Company | Substituted 1,2,3,4-tetahydroisoquinolines with angiotensin II receptor antagonist properties |
NL9201230A (nl) | 1992-07-09 | 1994-02-01 | Dsm Nv | Werkwijze voor de bereiding van optisch aktief methionineamide. |
EP0640594A1 (en) | 1993-08-23 | 1995-03-01 | Fujirebio Inc. | Hydantoin derivative as metalloprotease inhibitor |
JPH07105549A (ja) | 1993-09-30 | 1995-04-21 | Canon Inc | 光学的情報記録再生方法及び光学的情報記録再生装置 |
AU687953B2 (en) | 1993-11-16 | 1998-03-05 | Merck & Co., Inc. | Piperidinylcamphorsulfonyl oxytocin antagonists |
ATE183184T1 (de) | 1994-01-31 | 1999-08-15 | Pfizer | Neuroprotektive chroman verbindungen |
DE69534213T2 (de) | 1994-10-25 | 2006-01-12 | Astrazeneca Ab | Therapeutisch wirksame Heterocyclen |
ZA96211B (en) | 1995-01-12 | 1996-07-26 | Teva Pharma | Compositions containing and methods of using 1- aminoindan and derivatives thereof and process for preparing optically active 1-aminoindan derivatives |
US5863949A (en) | 1995-03-08 | 1999-01-26 | Pfizer Inc | Arylsulfonylamino hydroxamic acid derivatives |
US6166041A (en) | 1995-10-11 | 2000-12-26 | Euro-Celtique, S.A. | 2-heteroaryl and 2-heterocyclic benzoxazoles as PDE IV inhibitors for the treatment of asthma |
CZ291337B6 (cs) * | 1995-11-22 | 2003-02-12 | Darwin Discovery Limited | Merkaptoalkylpeptidylová sloučenina, její použití pro výrobu přípravku pro léčení nebo prevenci stavu souvisejícího s metalloproteinázou nebo TNFalfa a farmaceutický přípravek ji obsahující |
GB9616643D0 (en) * | 1996-08-08 | 1996-09-25 | Chiroscience Ltd | Compounds |
US5919790A (en) * | 1996-10-11 | 1999-07-06 | Warner-Lambert Company | Hydroxamate inhibitors of interleukin-1β converting enzyme |
ES2171905T3 (es) * | 1996-10-22 | 2002-09-16 | Upjohn Co | Acidos alfa-amino sulfonilo hidroxamicos como inhibidores de metaloproteinasa de matriz. |
EP0983239A1 (en) * | 1997-05-06 | 2000-03-08 | Novo Nordisk A/S | Novel heterocyclic compounds |
DK0877019T3 (da) | 1997-05-09 | 2002-04-08 | Hoechst Ag | Substituerede diaminocarboxylsyrer |
JP2002504916A (ja) | 1997-06-21 | 2002-02-12 | ロシュ ダイアグノスティクス ゲゼルシャフト ミット ベシュレンクテル ハフツング | 抗転移及び抗腫瘍活性を有するバルビツール酸誘導体 |
DE19726427A1 (de) | 1997-06-23 | 1998-12-24 | Boehringer Mannheim Gmbh | Pyrimidin-2,4,6-trion-Derivate, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
CN1178906C (zh) * | 1997-07-31 | 2004-12-08 | 艾博特公司 | 基质金属蛋白酶的逆异羟肟酸盐抑制剂 |
TW514634B (en) | 1997-10-14 | 2002-12-21 | Lilly Co Eli | Process to make chiral compounds |
BR9814147A (pt) * | 1997-11-12 | 2000-10-03 | Darwin Discovery Ltd | "derivados de ácido carboxìlico e hidroxâmico tendo atividade inibitória de mmp e tnf" |
HUP0101176A3 (en) * | 1998-02-04 | 2002-06-28 | Novartis Ag | Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases, process for their preparation and pharmaceutical compositions containing them |
US6329418B1 (en) * | 1998-04-14 | 2001-12-11 | The Procter & Gamble Company | Substituted pyrrolidine hydroxamate metalloprotease inhibitors |
WO1999058528A1 (en) * | 1998-05-14 | 1999-11-18 | Bristol-Myers Squibb Pharma Company. | Substituted aryl hydroxamic acids as metalloproteinase inhibitors |
CN1295561A (zh) * | 1998-06-03 | 2001-05-16 | Gpinil控股公司 | N-杂环羧酸或羧酸等排物的n-结合氨磺酰 |
EP1087937A1 (en) | 1998-06-17 | 2001-04-04 | Du Pont Pharmaceuticals Company | Cyclic hydroxamic acids as metalloproteinase inhibitors |
FR2782082B3 (fr) | 1998-08-05 | 2000-09-22 | Sanofi Sa | Formes cristallines de (r)-(+)-n-[[3-[1-benzoyl-3-(3,4- dichlorophenyl)piperidin-3-yl]prop-1-yl]-4-phenylpiperidin-4 -yl]-n-methylacetamide (osanetant) et procede pour la preparation dudit compose |
US6339101B1 (en) * | 1998-08-14 | 2002-01-15 | Gpi Nil Holdings, Inc. | N-linked sulfonamides of N-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
JP2000127349A (ja) * | 1998-08-21 | 2000-05-09 | Komori Corp | 凹版印刷機 |
EP1107953A1 (en) | 1998-08-29 | 2001-06-20 | British Biotech Pharmaceuticals Limited | Hydroxamic acid derivatives as proteinase inhibitors |
GB9919776D0 (en) | 1998-08-31 | 1999-10-27 | Zeneca Ltd | Compoujnds |
EP1117616B1 (en) | 1998-10-07 | 2003-04-23 | Yazaki Corporation | Sol-gel process using porous mold |
EP1004578B1 (en) | 1998-11-05 | 2004-02-25 | Pfizer Products Inc. | 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
CZ20012006A3 (cs) | 1998-12-18 | 2002-03-13 | Axys Pharmaceuticals, Inc. | Sloučenina a farmaceutický prostředek |
AU1817700A (en) | 1998-12-31 | 2000-07-24 | Aventis Pharmaceuticals Inc. | 1-carboxymethyl-2-oxo-azepan derivatives useful as selective inhibitors of mmp-12 |
US6340691B1 (en) * | 1999-01-27 | 2002-01-22 | American Cyanamid Company | Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase and tace inhibitors |
EP1149843A4 (en) | 1999-01-28 | 2012-06-06 | Chugai Pharmaceutical Co Ltd | SUBSTITUTED PHENETHYLAMINE DERIVATIVES |
US6294694B1 (en) | 1999-06-04 | 2001-09-25 | Wisconsin Alumni Research Foundation | Matrix metalloproteinase inhibitors and method of using same |
GB9916562D0 (en) | 1999-07-14 | 1999-09-15 | Pharmacia & Upjohn Spa | 3-Arylsulfonyl-2-(substituted-methyl) propanoic acid derivatives as matrix metalloproteinase inhibitora |
US20020006920A1 (en) * | 1999-07-22 | 2002-01-17 | Robinson Ralph Pelton | Arylsulfonylamino hydroxamic acid derivatives |
US6266453B1 (en) | 1999-07-26 | 2001-07-24 | Computerized Medical Systems, Inc. | Automated image fusion/alignment system and method |
ES2258431T3 (es) * | 1999-08-02 | 2006-09-01 | F. Hoffmann-La Roche Ag | Proceso para la preparacion de derivados de benzotiofeno. |
YU9602A (sh) | 1999-08-12 | 2004-11-25 | Pharmacia Italia S.P.A. | Derivati 3(5)-amino-pirazola, postupak za njihovu izradu i njihova upotreba kao antitumornih agenasa |
JP3710964B2 (ja) | 1999-08-26 | 2005-10-26 | 富士通株式会社 | ディスプレイデバイスのレイアウト設計方法 |
SE9904044D0 (sv) | 1999-11-09 | 1999-11-09 | Astra Ab | Compounds |
US6525202B2 (en) | 2000-07-17 | 2003-02-25 | Wyeth | Cyclic amine phenyl beta-3 adrenergic receptor agonists |
US7335673B2 (en) | 2000-08-11 | 2008-02-26 | Kaken Pharmaceutical Co., Ltd. | 2,3-Diphenylpropionic acid derivatives or their salts, medicines or cell adhesion inhibitors containing the same, and their usage |
US20020065219A1 (en) * | 2000-08-15 | 2002-05-30 | Naidu B. Narasimhulu | Water soluble thiazolyl peptide derivatives |
WO2002020515A1 (en) | 2000-09-08 | 2002-03-14 | Abbott Laboratories | Oxazolidinone antibacterial agents |
US20020091107A1 (en) * | 2000-09-08 | 2002-07-11 | Madar David J. | Oxazolidinone antibacterial agents |
EP1191024A1 (en) | 2000-09-22 | 2002-03-27 | Harald Tschesche | Thiadiazines and their use as inhibitors of metalloproteinases |
SE0100902D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
SE0100903D0 (sv) | 2001-03-15 | 2001-03-15 | Astrazeneca Ab | Compounds |
MXPA03008180A (es) | 2001-03-15 | 2003-12-12 | Astrazeneca Ab | Inhibidores de metaloproteinasa. |
JP2004535411A (ja) * | 2001-05-25 | 2004-11-25 | ブリストルーマイヤーズ スクイブ カンパニー | マトリックスメタロプロテナーゼ及び/またはTNF−α転換酵素(TACE)の阻害剤としてのヒダントイン及び関連複素環化合物 |
GB0114004D0 (en) | 2001-06-08 | 2001-08-01 | Glaxo Group Ltd | Chemical compounds |
SE0103710D0 (sv) * | 2001-11-07 | 2001-11-07 | Astrazeneca Ab | Compounds |
KR20050010826A (ko) | 2002-06-05 | 2005-01-28 | 가부시키가이샤 가네카 | 광학 활성 α-메틸시스테인 유도체의 제조 방법 |
SE0202539D0 (sv) * | 2002-08-27 | 2002-08-27 | Astrazeneca Ab | Compounds |
SE0202692D0 (sv) | 2002-09-11 | 2002-09-11 | Astrazeneca Ab | Compounds |
SE0202693D0 (sv) | 2002-09-11 | 2002-09-11 | Astrazeneca Ab | Compounds |
GB0221250D0 (en) | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
GB0221246D0 (en) | 2002-09-13 | 2002-10-23 | Astrazeneca Ab | Compounds |
US6890913B2 (en) * | 2003-02-26 | 2005-05-10 | Food Industry Research And Development Institute | Chitosans |
US20040266832A1 (en) | 2003-06-26 | 2004-12-30 | Li Zheng J. | Crystal forms of 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl pyridine |
TWI220073B (en) | 2003-07-24 | 2004-08-01 | Au Optronics Corp | Method for manufacturing polysilicon film |
SE0401763D0 (sv) | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Compounds |
SE0401762D0 (sv) | 2004-07-05 | 2004-07-05 | Astrazeneca Ab | Novel compounds |
US7648992B2 (en) | 2004-07-05 | 2010-01-19 | Astrazeneca Ab | Hydantoin derivatives for the treatment of obstructive airway diseases |
SE0403086D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Compounds |
SE0403085D0 (sv) | 2004-12-17 | 2004-12-17 | Astrazeneca Ab | Novel componds |
TW200740769A (en) | 2006-03-16 | 2007-11-01 | Astrazeneca Ab | Novel process |
TW200800954A (en) * | 2006-03-16 | 2008-01-01 | Astrazeneca Ab | Novel crystal modifications |
TW200831488A (en) | 2006-11-29 | 2008-08-01 | Astrazeneca Ab | Novel compounds |
-
2001
- 2001-03-15 SE SE0100902A patent/SE0100902D0/xx unknown
-
2002
- 2002-03-13 CN CNB02809915XA patent/CN100526307C/zh not_active Expired - Fee Related
- 2002-03-13 AT AT02704037T patent/ATE484496T1/de not_active IP Right Cessation
- 2002-03-13 RU RU2003127733/04A patent/RU2285695C2/ru not_active IP Right Cessation
- 2002-03-13 JP JP2002573760A patent/JP4390457B2/ja not_active Expired - Fee Related
- 2002-03-13 AU AU2002237632A patent/AU2002237632B2/en not_active Ceased
- 2002-03-13 ES ES02704031T patent/ES2267986T3/es not_active Expired - Lifetime
- 2002-03-13 CN CNA200910147512XA patent/CN101602731A/zh active Pending
- 2002-03-13 AU AU2002237626A patent/AU2002237626B2/en not_active Ceased
- 2002-03-13 DE DE60238794T patent/DE60238794D1/de not_active Expired - Lifetime
- 2002-03-13 CZ CZ20032500A patent/CZ20032500A3/cs unknown
- 2002-03-13 UA UA2003098170A patent/UA77667C2/uk unknown
- 2002-03-13 PL PL02364707A patent/PL364707A1/xx not_active Application Discontinuation
- 2002-03-13 PL PL02365099A patent/PL365099A1/xx unknown
- 2002-03-13 EP EP02704031A patent/EP1370556B1/en not_active Expired - Lifetime
- 2002-03-13 CN CN2006101061525A patent/CN1962641B/zh not_active Expired - Fee Related
- 2002-03-13 SK SK1092-2003A patent/SK287834B6/sk not_active IP Right Cessation
- 2002-03-13 BR BR0207984-4A patent/BR0207984A/pt not_active IP Right Cessation
- 2002-03-13 HU HU0400327A patent/HUP0400327A3/hu unknown
- 2002-03-13 EE EEP200300451A patent/EE05364B1/xx not_active IP Right Cessation
- 2002-03-13 NZ NZ528107A patent/NZ528107A/en unknown
- 2002-03-13 EP EP02704037A patent/EP1370537B1/en not_active Expired - Lifetime
- 2002-03-13 JP JP2002573776A patent/JP2004527515A/ja not_active Withdrawn
- 2002-03-13 AT AT06008158T patent/ATE493406T1/de not_active IP Right Cessation
- 2002-03-13 HU HU0400202A patent/HUP0400202A3/hu unknown
- 2002-03-13 BR BR0207983-6A patent/BR0207983A/pt not_active IP Right Cessation
- 2002-03-13 NZ NZ528140A patent/NZ528140A/en not_active IP Right Cessation
- 2002-03-13 ES ES02704037T patent/ES2352246T3/es not_active Expired - Lifetime
- 2002-03-13 KR KR1020037011987A patent/KR100886315B1/ko not_active IP Right Cessation
- 2002-03-13 WO PCT/SE2002/000473 patent/WO2002074748A1/en active IP Right Grant
- 2002-03-13 DK DK02704031T patent/DK1370556T3/da active
- 2002-03-13 US US10/471,900 patent/US7427631B2/en not_active Expired - Fee Related
- 2002-03-13 HU HU0400194A patent/HUP0400194A3/hu unknown
- 2002-03-13 NZ NZ528106A patent/NZ528106A/en not_active IP Right Cessation
- 2002-03-13 PL PL364706A patent/PL205315B1/pl not_active IP Right Cessation
- 2002-03-13 US US10/471,500 patent/US20040106659A1/en not_active Abandoned
- 2002-03-13 MY MYPI20020904A patent/MY136141A/en unknown
- 2002-03-13 KR KR1020087017665A patent/KR100879905B1/ko not_active IP Right Cessation
- 2002-03-13 UA UA2003098168A patent/UA77408C2/uk unknown
- 2002-03-13 JP JP2002573757A patent/JP2004523581A/ja active Pending
- 2002-03-13 WO PCT/SE2002/000478 patent/WO2002074751A1/en active Application Filing
- 2002-03-13 IL IL15765702A patent/IL157657A0/xx unknown
- 2002-03-13 EE EEP200300449A patent/EE200300449A/xx unknown
- 2002-03-13 IL IL15765202A patent/IL157652A0/xx unknown
- 2002-03-13 CN CNB028097882A patent/CN1304377C/zh not_active Expired - Fee Related
- 2002-03-13 BR BR0208104-0A patent/BR0208104A/pt not_active IP Right Cessation
- 2002-03-13 MX MXPA03008177A patent/MXPA03008177A/es active IP Right Grant
- 2002-03-13 SI SI200230386T patent/SI1370556T1/sl unknown
- 2002-03-13 CA CA2440473A patent/CA2440473C/en not_active Expired - Fee Related
- 2002-03-13 US US10/471,810 patent/US7368465B2/en not_active Expired - Fee Related
- 2002-03-13 KR KR10-2003-7011981A patent/KR20030082986A/ko not_active IP Right Cessation
- 2002-03-13 IL IL15765602A patent/IL157656A0/xx unknown
- 2002-03-13 MX MXPA03008191A patent/MXPA03008191A/es active IP Right Grant
- 2002-03-13 CZ CZ20032499A patent/CZ20032499A3/cs unknown
- 2002-03-13 DE DE60213216T patent/DE60213216T2/de not_active Expired - Lifetime
- 2002-03-13 ES ES06008158T patent/ES2357138T3/es not_active Expired - Lifetime
- 2002-03-13 SK SK1096-2003A patent/SK287766B6/sk not_active IP Right Cessation
- 2002-03-13 AT AT02704031T patent/ATE333454T1/de active
- 2002-03-13 CA CA2440630A patent/CA2440630C/en not_active Expired - Fee Related
- 2002-03-13 EE EEP200300445A patent/EE05431B1/xx not_active IP Right Cessation
- 2002-03-13 EP EP06008158A patent/EP1676846B1/en not_active Expired - Lifetime
- 2002-03-13 SK SK1095-2003A patent/SK10952003A3/sk not_active Application Discontinuation
- 2002-03-13 EP EP02704032A patent/EP1370534A1/en not_active Withdrawn
- 2002-03-13 CZ CZ20032497A patent/CZ20032497A3/cs unknown
- 2002-03-13 RU RU2003127735/04A patent/RU2293729C2/ru not_active IP Right Cessation
- 2002-03-13 UA UA2003098171A patent/UA78502C2/uk unknown
- 2002-03-13 CA CA002440631A patent/CA2440631A1/en not_active Abandoned
- 2002-03-13 DE DE60237965T patent/DE60237965D1/de not_active Expired - Lifetime
- 2002-03-13 MX MXPA03008181A patent/MXPA03008181A/es unknown
- 2002-03-13 KR KR10-2003-7011982A patent/KR20030082987A/ko not_active Application Discontinuation
- 2002-03-13 WO PCT/SE2002/000472 patent/WO2002074767A1/en active IP Right Grant
- 2002-03-13 PT PT02704031T patent/PT1370556E/pt unknown
- 2002-03-13 MY MYPI20020910A patent/MY136789A/en unknown
- 2002-03-13 CN CNB02810093XA patent/CN1269804C/zh not_active Expired - Fee Related
- 2002-03-13 RU RU2003127734/04A patent/RU2288228C2/ru not_active IP Right Cessation
- 2002-03-15 AR ARP020100943A patent/AR035695A1/es unknown
- 2002-03-15 AR ARP020100944A patent/AR035443A1/es active IP Right Grant
-
2003
- 2003-08-28 ZA ZA200306734A patent/ZA200306734B/en unknown
- 2003-08-28 ZA ZA200306732A patent/ZA200306732B/en unknown
- 2003-08-28 ZA ZA200306731A patent/ZA200306731B/en unknown
- 2003-08-28 ZA ZA200306737A patent/ZA200306737B/en unknown
- 2003-08-28 IL IL157652A patent/IL157652A/en not_active IP Right Cessation
- 2003-08-28 IL IL157656A patent/IL157656A/en not_active IP Right Cessation
- 2003-09-09 IS IS6942A patent/IS6942A/is unknown
- 2003-09-09 IS IS6943A patent/IS6943A/is unknown
- 2003-09-10 IS IS6946A patent/IS6946A/is unknown
- 2003-09-12 NO NO20034042A patent/NO326087B1/no not_active IP Right Cessation
- 2003-09-12 NO NO20034044A patent/NO20034044L/no unknown
- 2003-09-12 NO NO20034045A patent/NO327114B1/no not_active IP Right Cessation
-
2004
- 2004-04-21 HK HK06112181.8A patent/HK1091492A1/xx not_active IP Right Cessation
- 2004-04-21 HK HK04102796A patent/HK1059932A1/xx not_active IP Right Cessation
- 2004-04-23 HK HK04102888.7A patent/HK1060121A1/xx not_active IP Right Cessation
-
2006
- 2006-10-13 CY CY20061101477T patent/CY1107525T1/el unknown
-
2007
- 2007-10-30 US US11/928,040 patent/US7625934B2/en not_active Expired - Fee Related
-
2008
- 2008-05-05 US US12/114,901 patent/US7666892B2/en not_active Expired - Fee Related
- 2008-05-06 US US12/115,785 patent/US7754750B2/en not_active Expired - Fee Related
-
2009
- 2009-11-09 JP JP2009256358A patent/JP5140058B2/ja not_active Expired - Fee Related
-
2010
- 2010-01-26 US US12/693,852 patent/US8153673B2/en not_active Expired - Fee Related
- 2010-07-06 US US12/830,763 patent/US20110003853A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0100902D0 (sv) | Compounds | |
DE69809187T2 (de) | Metalloproteinase-Inhibitoren | |
SE0100903D0 (sv) | Compounds | |
IL159418A0 (en) | Novel compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents | |
DK1385514T5 (da) | Spiroinden- og spiroindanforbindelser | |
DE60230266D1 (de) | Phenylpyridincarbonyl piperazinderivate | |
CY1106247T1 (el) | Θειοφαινο- και θειαζολοσουλφοναμιδες ως αντινεοπλαστικοι παραγοντες | |
BR9804214A (pt) | Compostos. | |
DE69803907D1 (de) | Fungizide 2-Methoxybenzophenone | |
BR0209149A (pt) | Ftalazinonas | |
SE0103710D0 (sv) | Compounds | |
ATE403431T1 (de) | Benzimidazolon-verbindungen | |
EA200801365A1 (ru) | Замещенные 5-фенил-3,6-дигидро-2-оксо-6h-1,3,4-тиадиазины | |
MY128164A (en) | Compounds | |
DE60202669D1 (de) | 6-phenylbenzonaphthyidine | |
BR0206922A (pt) | Compostos orgânicos | |
BR9902096A (pt) | Pitazóis. | |
DE60039695D1 (de) | Antifucoidan antikörper | |
AR024797A1 (es) | Forma cristalina iii de la n-(4-(5-dimetilaminonaftalen-1-sulfonilamino)fenil)-3-hidroxi-2,2-dimetilpropionamida |